Blog

Follow us for the latest trends, insights and
innovations in the pharmaceutical industry.
Blog cover for hidden costs of switching pharmaceutical‑intermediate suppliers, buyer cost‑calculator guide for pharma procurement

The Hidden Cost of Switching Pharmaceutical Intermediate Suppliers: A Buyer’s Calculator

Switching intermediate suppliers for 20% lower price? Six hidden costs including bridging studies, regulatory filings, and method revalidation can reach $600K.
Read More →
Blog cover for ICH Q2 Analytical Method Validation guide, hidden facts about intermediate COA certificate of analysis pharmaceutical quality control

ICH Q2 Analytical Method Validation: What Your Intermediate COA Doesn’t Tell You

This guide decodes the seven validation parameters defined in ICH Q2(R2) from an intermediate buyer's perspective, explains why stability-indicating methods matter for retest dating, and ...
Read More →
Blog cover for ICH Q11 Starting Material Selection practical guide, structural fragment judgment, custom intermediate sourcing, supplier document audit and compliance risk control for pharmaceutical procurement teams

ICH Q11 Starting Material Selection: A Practical Guide for Pharmaceutical Intermediate Buyers

Learn how ICH Q11 starting material rules affect pharmaceutical intermediate sourcing—supplier boundaries, COA red flags, and a practical buyer's checklist.
Read More →
Blog cover Polymorphism in Pharmaceutical Intermediates guide, solid form management, ritonavir crystal case, ICH Q6A rule and polymorph risk check on supplier COA for pharma purchasers

Polymorphism in Pharmaceutical Intermediates: Why Solid Form Control Matters

This guide explains what polymorphism means for intermediate buyers, how ICH Q6A Decision Tree #4 governs solid form control, which COA red flags signal polymorph ...
Read More →
Scroll to Top

Contact us to Get the Best Product Solution